Auditorium
Seminar

TRI TUESDAY SEMINAR SERIES

Planning for the 2018 schedule is underway with the full schedule to be released soon. 

The Tuesday Seminar series is held on the first Tuesday of each month. The objectives of this seminar series are to build further knowledge in innovative medical research, development and translation; and to attract renown speakers on topics that will be relevant to a broad audience.

The Tuesday Seminars are free to attend, simply come along to the Auditorium at the TRI building, no RSVP is required. 

2018 Schedule

Date & Time

Time Featured Speaker TRI Host Details 

Tuesday 20 March 

12.00 - 1.00pm 

Dr Cameron Turtle 

Fred Hutch Cancer Centre Seattle, Clinical Trials Immunotherapy 

Dr Kristen Radford, Mater

Dr. Turtle is currently an Attending Physician on the Fred Hutch Bone Marrow Transplant Program and the Immunotherapy Service at the Seattle Cancer Care Alliance (SCCA), a cancer treatment center that unites doctors from Fred Hutch, University of Washington Medicine and Seattle Children’s Hospital.

Dr Cameron Turtle Full Biography 

TRI based researchers, if you'd like to nominate a speaker, please contact them to ascertain their availability. If the speaker would like to present at TRI, please complete the online form and submit to the Personal Development and Talent Management Committee who will evaluate each submission. If you have any questions, please email: [email protected]

2017 Speaker Archive

Date & Time

Time Featured Speaker TRI Host Title & Abstract

30 May 2017 *Please note date change

12.00 - 1.00pm 

Prof Alan Mackay-Sim, 2017 Australian of the Year

Dr Alexandre Cristino

Hereditary Spastic Paraplegia: from stem cells to drug discovery

6 June 2017

12.00 - 1.00pm 

A/Prof Michael Samuel, Head Tumour Microenvironment Lab, Centre for Cancer Biology,

SA Pathology & the University of South Australia

Prof Rik Thompson

Biochemical and biomechanical inter-relationships in cancer and wound healing

20 June 2017 12.00 - 1.00pm  Prof Cornellia Weyand, Medicine - Immunology and Rheumatology, Stanford Prof Ranjeny Thomas Immunometabolic Signatures in Autoimmunity
4 July 2017 12.00 - 1.00pm Professor Nick Graves, Health Economist, QUT Professor Gerald Holtmann Are we overpowering intervention studies? P-values, Clinical Trials and Waste in Research 
25 July 2017 12.00 - 1.00pm Dr Jonathan Sherlock, Kennedy Institute of Rhuematology, University of Oxford Prof Ranjeny Thomas Immunological pathways implicated in autoimmune diseases
8 August  12.00 - 1.00pm Professor Carl Walkley, St Vincent's Institute of Medical Research Melbourne Mater Research

Title: Rewriting the transcriptome: ADAR1 mediated A-to-I RNA editing

One of the most prevalent forms of post-transcriptional RNA modification is the conversion of adenosine bases to inosine (A-to-I), mediated by the ADAR family of enzymes. A-to-I editing is a widespread feature of the transcriptome, with estimates ranging from tens of thousands in mice to millions of A-to-I editing events in humans and primates. We have used in vivo haematology as a system to understand how RNA editing by ADAR1 regulates the transcriptome, and how this interfaces with the innate immune system and enables discrimination of self and non-self nucleic acids.​

5 September 9am-5pm Imagine  Professor Carolyn Mountford

Imagine 2017 

3 October 2017 12.00 - 1.00pm Prof Roger Daly, Molecular Biology, Monash University  Prof Brian Gabrielle Protein kinase signalling networks in human cancer
19 October 2017 12.00 - 1.00pm   Prof Brian Gabrielle World Melanoma Congress